CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
96.58
2.33%
Market Trading Hours* (UTC) Opens on Friday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.18
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024262 %
Charges from full value of position ($-4.61)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00204 %
Charges from full value of position ($0.39)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00204%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 98.88
Open 98.8
1-Year Change -70.82%
Day's Range 96.58 - 98.8
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 12, 2024 96.58 -2.43 -2.45% 99.01 99.09 96.54
Dec 11, 2024 98.88 0.37 0.38% 98.51 99.97 98.46
Dec 10, 2024 98.79 -0.39 -0.39% 99.18 100.02 97.72
Dec 9, 2024 98.94 0.87 0.89% 98.07 100.30 98.05
Dec 6, 2024 98.65 1.03 1.06% 97.62 101.24 97.19
Dec 5, 2024 103.15 0.04 0.04% 103.11 104.23 102.70
Dec 4, 2024 104.66 1.97 1.92% 102.69 106.35 102.25
Dec 3, 2024 102.98 0.46 0.45% 102.52 103.87 100.96
Dec 2, 2024 102.91 -0.54 -0.52% 103.45 104.17 102.44
Nov 29, 2024 104.11 0.69 0.67% 103.42 104.58 102.98
Nov 27, 2024 103.09 1.53 1.51% 101.56 103.39 101.49
Nov 26, 2024 102.33 0.51 0.50% 101.82 103.00 100.77
Nov 25, 2024 102.04 0.54 0.53% 101.50 103.22 100.79
Nov 22, 2024 100.75 1.89 1.91% 98.86 101.10 98.85
Nov 21, 2024 99.84 1.92 1.96% 97.92 99.97 97.41
Nov 20, 2024 98.78 1.33 1.36% 97.45 99.11 97.10
Nov 19, 2024 98.95 0.92 0.94% 98.03 99.81 97.57
Nov 18, 2024 99.37 0.42 0.42% 98.95 99.85 98.62
Nov 15, 2024 99.25 -0.70 -0.70% 99.95 100.69 98.71
Nov 14, 2024 99.78 -1.13 -1.12% 100.91 101.46 99.28

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cooper Company profile

About Cooper Companies Inc

The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Financial summary

BRIEF: For the three months ended 31 January 2022, Cooper Companies Inc revenues increased 16% to $787.2M. Net income decreased 95% to $95.3M. Revenues reflect CooperVision segment increase of 11% to $561.5M, CooperSurgical segment increase of 30% to $225.7M, United States segment increase of 17% to $365.3M, Europe segment increase of 13% to $250.4M, Rest of the World segment increase of 17% to $171.5M.

Equity composition

Common Stock $.10 Par, 1/11, 70M auth., 46,473,000 issd., less 282,000 shs. in Treas. @ $4.3M. Insiders & Strategic Owns 0.70%. PO7/97,2M shs. @ $23.50 by Deutsche Morgan Grenfell. 11/02, 2-for-1 split; 9/95, 1-for-3 reverse stock split. FY'05 Qs are being restated. Summ. Q's reflect RES for FY'05.

Industry: Glasses, Spectacles & Contact Lenses

6101 Bollinger Canyon Road
Suite 500
SAN RAMON
CALIFORNIA 94583
US

People also watch

XRP/USD

2.35 Price
-0.690% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01173

Oil - Crude

70.56 Price
+1.200% 1D Chg, %
Long position overnight fee 0.0085%
Short position overnight fee -0.0305%
Overnight fee time 22:00 (UTC)
Spread 0.030

ETH/USD

3,919.50 Price
+1.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

100,622.35 Price
+0.740% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading